$CYDY CytoDyn Announces Leadership Transition Plan to Support Regulatory Approval and Commercialization of Leronlimab

on January 25, 2022 News and Tags: , , , with 0 comments
Time:
6:06 PM
Symbol:
CYDY
Company:
CytoDyn Inc.
Source:
Business Wire News Releases
Read more

CytoDyn Inc. $CYDY – end of day report for January 13, 2022

on January 13, 2022 End of Day Reports and Tags: , with 0 comments
Close:
0.680
Change:
26%
Read more

CytoDyn Inc. $CYDY – end of day report for January 11, 2022

on January 11, 2022 End of Day Reports and Tags: , with 0 comments
Close:
0.556
Change:
-21%
Read more

$CYDY Leronlimab 14-Week, NASH Clinical Trial Met Primary Endpoint (PDFF) and Secondary Endpoint (cT1) for Per Protocol Population in 350 mg Weekly Dose

on January 5, 2022 News and Tags: , , , with 0 comments
Time:
9:26 AM
Symbol:
CYDY
Company:
CytoDyn Inc.
Source:
Business Wire News Releases
Read more

$CYDY CytoDyn Announces Favorable Ruling Granting Injunction Against Former CRO

on December 22, 2021 News and Tags: , , , with 0 comments
Time:
8:39 AM
Symbol:
CYDY
Company:
CytoDyn Inc.
Source:
Business Wire News Releases
Read more

$CYDY CytoDyn Receives Positive Response From FDA in Regard to its Phase 3, Registrational Trial in COVID-19 Critically Ill Population

on December 21, 2021 News and Tags: , , , with 0 comments
Time:
8:56 AM
Symbol:
CYDY
Company:
CytoDyn Inc.
Source:
Business Wire News Releases
Read more

$CYDY NASH Phase 2 Trial Open-Label Portion Demonstrates Average 80 msec cT1 Reduction in 50% of Patients and Reduction of Nearly 50 msec in 80% of Patients

on December 13, 2021 News and Tags: , , , with 0 comments
Time:
8:00 AM
Symbol:
CYDY
Company:
CytoDyn Inc.
Source:
Business Wire News Releases
Read more

$CYDY CytoDyn Files for Expanded Access Use of Leronlimab for Multi-Drug Resistance HIV Patients

on December 9, 2021 News and Tags: , , , with 0 comments
Time:
8:26 AM
Symbol:
CYDY
Company:
CytoDyn Inc.
Source:
Business Wire News Releases
Read more

$CYDY CytoDyn Inc. Announces Adjournment of Annual Meeting of Shareholders to November 24, 2021 Due to Lack of Quorum

on October 28, 2021 News and Tags: , , , with 0 comments
Time:
11:08 AM
Symbol:
CYDY
Company:
CytoDyn Inc.
Source:
Business Wire News Releases
Read more

$CYDY CytoDyn Announces Delaware Court Has Denied Activist Group’s Motion to Prevent Annual Meeting from Taking Place

on October 20, 2021 News and Tags: , , , with 0 comments
Time:
4:27 PM
Symbol:
CYDY
Company:
CytoDyn Inc.
Source:
Business Wire News Releases
Read more

$CYDY Group of CytoDyn Stockholders Comments on Delaware Court Decision

on October 14, 2021 News and Tags: , , , with 0 comments
Time:
11:38 AM
Symbol:
CYDY
Company:
CytoDyn Inc.
Source:
Business Wire News Releases
Read more

$CYDY Delaware Court Agrees with CytoDyn that Activist Group’s Nominations are Invalid

on October 14, 2021 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
CYDY
Company:
CytoDyn Inc.
Source:
Business Wire News Releases
Read more

$CANB CEO Presenting on the Emerging Growth Conference on September 29 Register Now

on September 28, 2021 News and Tags: , , , , , , , , , , , , , , , with 0 comments
Time:
7:00 AM
Symbol:
CANB
Company:
CAN B CORP.
Source:
GlobeNewswire News Releases
Read more

$CYDY Group of CytoDyn Stockholders Releases White Paper Regarding Company’s Extremely Unfavorable Borrowing Practices

on September 27, 2021 News and Tags: , , , with 0 comments
Time:
6:30 PM
Symbol:
CYDY
Company:
CytoDyn Inc.
Source:
Business Wire News Releases
Read more

$CYDY CytoDyn to Present at Emerging Growth Conference on September 29 Followed by Live Q/A

on September 27, 2021 News and Tags: , , , with 0 comments
Time:
12:30 PM
Symbol:
CYDY
Company:
CytoDyn Inc.
Source:
Business Wire News Releases
Read more

$CYDY Group of CytoDyn Stockholders Shares Strategic Plan to Obtain Cancer Therapy Approval for Leronlimab

on September 24, 2021 News and Tags: , , , with 0 comments
Time:
8:00 AM
Symbol:
CYDY
Company:
CytoDyn Inc.
Source:
Business Wire News Releases
Read more

$CYDY CytoDyn Receives Clearance from Brazil’s FDA (ANVISA) to Commence a Pivotal Phase 3 Trial in Critically Ill COVID-19 Patients with IV Administration of Four Doses (700mg/week)

on September 22, 2021 News and Tags: , , , with 0 comments
Time:
8:00 AM
Symbol:
CYDY
Company:
CytoDyn Inc.
Source:
Business Wire News Releases
Read more

$CRVS Accelerated Development of COVID-19 Vaccines to Combat Potential for Possible Future Viral Pathogens and Variants

on September 22, 2021 News and Tags: , , , , , , , , , , , , , , , with 0 comments
Time:
8:55 AM
Symbol:
CRVS
Source:
PR Newswire
Read more

$CYDY CytoDyn’s Chairman, CMO, and Head of Business Development Dr. Scott A. Kelly to Present at the World Antiviral Congress 2021

on September 21, 2021 News and Tags: , , , with 0 comments
Time:
8:00 AM
Symbol:
CYDY
Company:
CytoDyn Inc.
Source:
Business Wire News Releases
Read more

$CYDY Group of CytoDyn Stockholders Announces Federal Court Dismisses Litigation Brought by Company

on September 20, 2021 News and Tags: , , , with 0 comments
Time:
11:00 AM
Symbol:
CYDY
Company:
CytoDyn Inc.
Source:
Business Wire News Releases
Read more